Outcomes of Returning Medically Actionable Genomic Results in Pediatric Research
- PMID: 36422086
- PMCID: PMC9694255
- DOI: 10.3390/jpm12111910
Outcomes of Returning Medically Actionable Genomic Results in Pediatric Research
Abstract
Purpose: The electronic Medical Records and Genomics (eMERGE) Phase III study was undertaken to assess clinical utility of returning medically actionable genomic screening results. We assessed pediatric clinical outcomes following return of pathogenic/likely pathogenic (P/LP) variants in autosomal dominant conditions with available effective interventions.
Methods: The two eMERGE III pediatric sites collected outcome data and assessed changes in medical management at 6 and 12 months.
Results: We returned P/LP results to 29 participants with outcome data. For 23 of the 29 participants, the P/LP results were previously unknown. Five of the 23 participants were already followed for conditions related to the P/LP variant. Of those receiving novel results and not being followed for the condition related to the P/LP result (n = 18), 14 (77.8%) had a change in healthcare after return of results (RoR). Following RoR, cascade testing of family members occurred for 10 of 23 (43.5%).
Conclusions: The most common outcomes post-RoR included imaging/laboratory testing and health behavior recommendations. A change in healthcare was documented in 77.8% of those receiving results by 6 months. Our findings demonstrate how return of genomic screening results impacts healthcare in pediatric populations.
Keywords: genomic screening; healthcare outcomes; pediatric genomics; return of genomic results.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Yeung A., Tan N.B., Tan T.Y., Stark Z., Brown N., Hunter M.F., Delatycki M., Stutterd C., Savarirayan R., Mcgillivray G. A cost-effectiveness analysis of genomic sequencing in a prospective versus historical cohort of complex pediatric patients. Genet. Med. 2020;22:1986–1993. doi: 10.1038/s41436-020-0929-8. - DOI - PubMed
-
- Smith H.S., Swint J.M., Lalani S.R., Yamal J.-M., de Oliveira Otto M.C., Castellanos S., Taylor A., Lee B.H., Russell H.V. Clinical application of genome and exome sequencing as a diagnostic tool for pediatric patients: A scoping review of the literature. Genet. Med. 2019;21:3–16. doi: 10.1038/s41436-018-0024-6. - DOI - PubMed
-
- Cakici J.A., Dimmock D.P., Caylor S.A., Gaughran M., Clarke C., Triplett C., Clark M.M., Kingsmore S.F., Bloss C.S. A prospective study of parental perceptions of rapid whole-genome and-exome sequencing among seriously ill infants. Am. J. Hum. Genet. 2020;107:953–962. doi: 10.1016/j.ajhg.2020.10.004. - DOI - PMC - PubMed
-
- Williams J.L., Chung W.K., Fedotov A., Kiryluk K., Weng C., Connolly J.J., Harr M., Hakonarson H., Leppig K.A., Larson E.B. The Road from Nanomedicine to Precision Medicine. Jenny Stanford Publishing; Stanford, CA, USA: 2020. Harmonizing outcomes for genomic medicine: Comparison of eMERGE outcomes to ClinGen outcome/intervention pairs; pp. 871–899. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
